9 Mar 2020 11:07
4D pharma plc
("4D pharma" or the "Company")
Result of General Meeting
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutic products, announces that, at the General Meeting held earlier today to enable the proposed issue of a total of 44,000,000 New Ordinary Shares in connection with the Placing and Subscription to raise gross proceeds of £22 million, all Resolutions were duly passed.
Further to the Result of Placing announcement made on 18 February 2020, 27,176,920 Subscription Shares and 16,823,080 Placing Shares will be issued. The total number of New Ordinary Shares to be issued pursuant to the Subscription and Placing remains unchanged.
Application has been made to the London Stock Exchange for the 44,000,000 New Ordinary Shares to be admitted to trading on AIM and it is expected that Admission will occur and dealings commence at 8.00 a.m. tomorrow, 10 March 2020.
Total Voting Rights
Following Admission, the Company will have 109,493,842 Ordinary Shares in issue. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. There Company holds no Ordinary Shares in treasury.
Block Admission
A block admission has been made in respect of 22,000,000 shares which may arise from the exercise of Warrants issued in connection with the Fundraising ("Warrant Shares") under the scheme name '4D March 2020 Warrants'. Admission of the block listed shares will also take effect on 10 March 2020. For the avoidance of doubt, the Warrants themselves will not be admitted to Trading on AIM. Each Warrant entitles the holder to subscribe for one Ordinary Share at a price of 100 pence at any time up to 10 March 2025.
Definitions
Capitalised terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to them in the announcement made by the Company on 18 February 2020 to announce the launch of the Placing.
For further information please contact: | ||||||||||||||
|